Daily coverage of equity markets, sectors, and major indices.
In-depth reporting on U.S. and global stock markets, including index performance, sector rotation, earnings reactions, volatility trends, and notable single-stock moves. Designed to help traders and investors understand what is driving price action across equities.
20,609 total articles
Raymond James upgraded American Homes 4 Rent and Invitation Homes to Outperform, setting target prices of $35 and $32 respectively, after revisions to the proposed 21st Century ROAD to Housing Act removed provisions seen as restrictive to institutional single-family rental owners. The firm also pointed to improving leasing activity, a cost advantag…
The U.S. Department of the Treasury said it agreed to a $275 million settlement with Adani Enterprises Ltd to resolve potential civil liability stemming from 32 apparent violations of U.S. sanctions on Iran. Treasury's Office of Foreign Assets Control said the violations involved purchases of liquefied petroleum gas that originated in Iran but were…
The U.S. Supreme Court on Monday refused to take up appeals from six major pharmaceutical companies contesting a Medicare drug price negotiation program established under the Inflation Reduction Act of 2022. By declining review, the justices left intact lower court decisions that rejected the companies' constitutional and administrative law claims,…
President Donald Trump told Fortune he had asked Intel CEO Lip-Bu Tan for a 10% stake for free when the U.S. government converted federal support into equity last year. Trump said he "should have asked for more" as Intel's stock has climbed more than 300% since the government took a 9.9% holding. The equity came from converting CHIPS Act grants and…
Regeneron shares fell sharply after its experimental combination of fianlimab and cemiplimab failed to meet the main goal in a late-stage trial for advanced melanoma. The company faces mounting pipeline scrutiny following other recent clinical and regulatory setbacks, even as it pursues a separate head-to-head study and a new partnership with Parab…
Bank of America’s April read of Placer.ai foot traffic for publicly traded hospital operators shows Tenet Healthcare with a positive acceleration in visits that implies second-quarter volume growth above consensus, while HCA Healthcare appears neutral and peers Universal Health Services and Acadia lag consensus expectations.
The US Supreme Court declined to hear Eli Lilly's appeal of a $194 million judgment in a whistleblower suit accusing the drugmaker of understating revenues from wholesalers to reduce Medicaid rebate obligations. The company had sought to overturn the False Claims Act on constitutional grounds but the justices refused to take the case.
Summary: Capita Plc shares rose sharply after the company released a trading update covering the four months to 30 April 2026 that showed revenue growth and contract wins, and announced the appointment of a Non-Executive Director linked to a significant shareholder. Management reiterated a strategy to concentrate on higher-margin public service and…
Ryanair CEO Michael O’Leary cautioned that an extended Iran war and ongoing restrictions in the Strait of Hormuz could force European airlines into collapse. He singled out Wizz Air and Air Baltic as particularly vulnerable, questioned the recoverability of government support, and said Ryanair would consider buying aircraft if carriers sell assets.
Citigroup and HPS Investment Partners, part of BlackRock, have established a 15 billion euro ($17.48 billion) private credit program to expand direct lending across the EMEA region. Citi will source opportunities while the program targets sub-investment grade debt across an initial five-year term, focusing on borrowers with businesses in Continenta…
The U.S. Supreme Court refused to hear Eli Lilly’s appeal of a lower-court ruling that affirmed a $183 million judgment under the False Claims Act, leaving intact a verdict that stemmed from a 2014 whistleblower suit alleging improper Medicaid rebates. The decision preserves the operation of the qui tam provisions that let private citizens sue on t…
ServiceNow stock climbed in morning trading after BofA Securities initiated coverage with a Buy rating and a $130 price target, citing the company’s entrenched role in enterprise workflows and potential to benefit from AI. Other firms have also reiterated bullish views tied to AI governance and orchestration. Recent quarterly results showing robust…
Barclays says select European food and household product companies are better placed than peers to navigate a renewed round of cost pressures that differ from the 2022-23 cycle. The bank singles out Unilever, L'Oréal, Haleon and Danone as companies where execution quality, portfolio positioning and brand strength are likely to separate winners from…
Regeneron Pharmaceuticals stock plunged after a Phase 3 study testing fianlimab, a LAG-3 inhibitor, together with cemiplimab failed to achieve statistical significance for its primary endpoint of improved progression-free survival versus pembrolizumab monotherapy in first-line unresectable or metastatic melanoma. The regimen produced a 5.1-month nu…
Bank of America has increased its 2026 S&P 500 earnings-per-share estimate to $335, signaling 22% year-over-year growth, while maintaining a guarded stance on the index overall. Analyst Savita Subramanian disputes the popular view that semiconductors are in a valuation bubble and software stocks are cheap, pointing to upgraded semiconductor earning…
Cerebras Systems stock climbed 5.56% to $295.27 in morning trading as buyers returned after a sharp post-IPO pullback. The recovery is supported by a 76% revenue increase to $510 million, a swing to $88 million in net income, major hyperscaler agreements with OpenAI and Amazon Web Services, and institutional purchases by ARK Invest.
Citigroup and BlackRock’s private credit arm HPS Investment Partners have agreed to jointly originate and structure direct loans across Europe under a new Citi/HPS Private Capital Program. The initiative will pursue as much as €15 billion of sub-investment grade financings over five years, covering senior and junior credit for corporate and private…
York Space Systems Inc. shares climbed about 8.37% in morning trading as investor attention refocused on the company's definitive agreement to acquire ALL.SPACE. The deal, analyst support, insider purchases and management's reaffirmed guidance outweighed investor reaction to mixed Q1 2026 results that had prompted a steep selloff last week.
Catalyst Brands plans to expand the headcount at its Bengaluru global capability centre to roughly 1,000 employees by year-end, increasing from about 650 at the start of the year. The move reflects a transfer of a greater share of global work to India, with Bengaluru assuming broader duties across digital operations, creative services, planning and…
Olympus Corp. shares climbed after the company reported FY2026 results showing a modest revenue increase but a decline in adjusted operating profit largely tied to FDA-related disruptions. A fourth-quarter rebound in shipments, a refreshed capital allocation plan including up to ¥60 billion in share repurchases, and an analyst upgrade tied to new e…
Quantum Cyber N.V. (NASDAQ:QUCY) announced the incorporation of a Nevada-based, wholly owned subsidiary, Quantum Drones Corporation, to drive its domestic defense technology initiatives and target U.S. government procurement. The move coincided with a 22.3% premarket jump in QUCY shares. Leadership appointments and stated budget opportunities for d…
Boston Scientific announced a $2 billion accelerated share repurchase with JPMorgan Chase Bank and a separate $1.5 billion equity investment in MiRus LLC, prompting a modest premarket uptick in its stock. The transactions are part of an existing $5 billion buyback authorization and include an option to acquire MiRus' investigational SIEGEL TAVR sys…
BofA Securities upgraded its year-end targets for Japan’s equity benchmarks on the back of stronger-than-expected corporate earnings tied to a surge in AI investment. The bank now targets TOPIX at 4,200 and the Nikkei 225 at 67,000, citing robust recurring profit growth and Japan’s role in the AI supply chain, while cautioning that the recent rally…
Can-Fite BioPharma saw a premarket share increase after a peer-reviewed study in Frontiers in Veterinary Science reported that oral Piclidenoson improved mobility and pain measures in dogs with osteoarthritis while maintaining a favorable safety profile. The drug is being developed for veterinary use by Vetbiolix under a license potentially worth u…
UnitedHealth Group shares fell about 3% after Berkshire Hathaway announced it had sold its stake in the health insurer as part of first-quarter portfolio changes under CEO Greg Abel. The move follows Berkshire's August purchase of 5 million UnitedHealth shares and comes as UnitedHealth has posted stronger quarterly results and lifted its annual pro…
